CA2483747A1 - Cells for detection of influenza and parainfluenza viruses - Google Patents

Cells for detection of influenza and parainfluenza viruses Download PDF

Info

Publication number
CA2483747A1
CA2483747A1 CA002483747A CA2483747A CA2483747A1 CA 2483747 A1 CA2483747 A1 CA 2483747A1 CA 002483747 A CA002483747 A CA 002483747A CA 2483747 A CA2483747 A CA 2483747A CA 2483747 A1 CA2483747 A1 CA 2483747A1
Authority
CA
Canada
Prior art keywords
virus
cell
influenza
cells
mv1lu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002483747A
Other languages
English (en)
French (fr)
Inventor
Yung T. Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Hospitals of Cleveland
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2483747A1 publication Critical patent/CA2483747A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA002483747A 2002-04-25 2003-04-17 Cells for detection of influenza and parainfluenza viruses Abandoned CA2483747A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/133,910 US6610474B1 (en) 2002-04-25 2002-04-25 Cells for detection of influenza and parainfluenza viruses
US10/133,910 2002-04-25
PCT/US2003/012203 WO2003091459A1 (en) 2002-04-25 2003-04-17 Cells for detection of influenza and parainfluenza viruses

Publications (1)

Publication Number Publication Date
CA2483747A1 true CA2483747A1 (en) 2003-11-06

Family

ID=27754313

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002483747A Abandoned CA2483747A1 (en) 2002-04-25 2003-04-17 Cells for detection of influenza and parainfluenza viruses

Country Status (8)

Country Link
US (3) US6610474B1 (https=)
EP (1) EP1497468B1 (https=)
JP (1) JP2005523709A (https=)
AT (1) ATE428810T1 (https=)
AU (1) AU2003228607B2 (https=)
CA (1) CA2483747A1 (https=)
DE (1) DE60327190D1 (https=)
WO (1) WO2003091459A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233674A1 (en) * 2002-04-25 2010-09-16 University Hospitals Of Cleveland Cells for detection and production of influenza and parainfluenza viruses
US7150965B2 (en) * 2003-04-17 2006-12-19 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses
US6610474B1 (en) * 2002-04-25 2003-08-26 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses
US7129042B2 (en) * 2003-11-03 2006-10-31 Diagnostic Hybrids, Inc. Compositions and methods for detecting severe acute respiratory syndrome coronavirus
US8318423B2 (en) 2004-07-06 2012-11-27 Focus Diagnostics, Inc. Methods and compositions for detecting rhinoviruses
US8084443B2 (en) 2007-10-01 2011-12-27 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
EP2772267B1 (en) * 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
EP2344634A4 (en) 2008-09-24 2012-08-29 Medimmune Llc METHODS OF CELL CULTURE, AND PROPAGATION AND PURIFICATION OF VIRUSES
US8376955B2 (en) * 2009-09-29 2013-02-19 Covidien Lp Spectroscopic method and system for assessing tissue temperature
EP3494989B1 (en) 2012-01-26 2025-07-16 Longhorn Vaccines and Diagnostics, LLC Composite antigenic sequences and vaccines
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
EP3294448A4 (en) 2015-05-14 2018-12-12 Longhorn Vaccines and Diagnostics, LLC Rapid methods for the extraction of nucleic acids from biological samples
EP3249406A1 (de) * 2016-05-27 2017-11-29 PerkinElmer Cellular Technologies Germany GmbH Verfahren zur bestimmung der anzahl von infektionsherden einer zellkultur
EP4036209A1 (en) * 2021-01-29 2022-08-03 Leica Microsystems CMS GmbH Microplate for containing a plurality of samples
CN115015549B (zh) * 2022-07-14 2023-01-13 深圳市卫光生物制品股份有限公司 一种狂犬病疫苗灭活验证的试验方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939253A (en) 1996-04-26 1999-08-17 Diagnostic Hybrids, Inc. Compositions and methods for detecting viral infection
US20020082224A1 (en) * 1997-01-14 2002-06-27 Douglas J. Jolly Non-immunogenic prodrugs and selectable markers for use in gene therapy
US6168915B1 (en) 1998-04-24 2001-01-02 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
US6610474B1 (en) * 2002-04-25 2003-08-26 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses

Also Published As

Publication number Publication date
EP1497468A4 (en) 2005-09-14
AU2003228607A1 (en) 2003-11-10
DE60327190D1 (de) 2009-05-28
EP1497468A1 (en) 2005-01-19
WO2003091459A1 (en) 2003-11-06
EP1497468B1 (en) 2009-04-15
US6610474B1 (en) 2003-08-26
US20030203357A1 (en) 2003-10-30
JP2005523709A (ja) 2005-08-11
ATE428810T1 (de) 2009-05-15
US6991899B2 (en) 2006-01-31
US20040234947A1 (en) 2004-11-25
AU2003228607B2 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
US6610474B1 (en) Cells for detection of influenza and parainfluenza viruses
Oldstone et al. Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus
Compans et al. Influenza virus proteins: I. Analysis of polypeptides of the virion and identification of spike glycoproteins
Defer et al. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C
KR100386738B1 (ko) 씨피45 에이치피아이브이-3 균주를 기재로 하는 생균 약독백신 및 상기 백신 내의 약독화를 확인하는 방법
JP5322636B2 (ja) インフルエンザウイルスの増殖方法
EP1071827B1 (en) Mixed cell diagnostic systems
US4707448A (en) Immortal line of human fetal glial cells
CN101613678A (zh) 稳定表达β-半乳糖苷α-2，3-唾液酸转移酶I(ST3GAL I)的MDCK细胞系的建立
McMILLEN et al. Origin of the polyoma virus-associated endonuclease
MXPA06012216A (es) Factor de tolerancia celular para virus y uso del mismo.
US8105767B2 (en) Cells for detection of enteroviruses
US7150965B2 (en) Cells for detection of influenza and parainfluenza viruses
US20100233674A1 (en) Cells for detection and production of influenza and parainfluenza viruses
AU2002254715A1 (en) Cells for detection of enteroviruses
Nishio et al. Characterization of Sendai virus persistently infected L929 cells and Sendai virus pi strain: recombinant Sendai viruses having Mpi protein shows lower cytotoxicity and are incapable of establishing persistent infection
JP3058438B2 (ja) ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
Leland et al. Virus isolation
US5830638A (en) Cell line and processes for the replicating rabies viruses and detecting them quantitatively
Skoog et al. Deoxyribonucleotide pools and deoxyribonucleic acid synthesis in mouse embryo cells infected with three classes of polyoma virus particles
AU2006203283B2 (en) Mixed cell systems for the detection of viruses
JP2023020424A (ja) シュードタイプウイルス集団及びその製造方法
FENG Development and characterization of a SARS-coronavirus replicon cell line
Horzinek Synthesis of togavirus RNA

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued